TB-500 & TB-4: benefits, safety,
and what the research shows.

Short answer

TB-500 is a synthetic peptide based on a fragment of Thymosin Beta-4 (TB-4), a naturally occurring protein found in nearly all human and animal cells. It is studied for cell migration, actin regulation and tissue repair. The strongest evidence is preclinical, and it is not an FDA-approved drug.

Evidence and status

TB-500 is not FDA-approved for any use, and compounded versions are not FDA-approved. Support comes mainly from animal and laboratory research; human data is limited. Everything below is described mechanisms and reported patterns — not promises.

What is TB-500 (and TB-4)?

Thymosin Beta-4 (TB-4) is a naturally occurring protein found in nearly all human and animal cells, with a well-studied role in cell migration and repair. TB-500 is a synthetic peptide based on an active fragment of TB-4 — often the two names are used loosely to mean the same thing, which is where confusion starts.

What does the peptide TB-4 do?

In animal and cell studies, TB-4 is described binding G-actin and regulating the actin cytoskeleton — the internal scaffolding cells use to move. That matters for repair because healing depends on cells migrating to the injury:

• promoting cell migration into damaged tissue;
• supporting new blood-vessel formation in models;
• modulating inflammation during early repair.

These are proposed mechanisms seen mostly in preclinical work — not established outcomes in people.

Is TB-4 better than TB-500?

It's not really a "better" question — it's a naming one. TB-4 is the parent protein; TB-500 is a synthetic fragment of it. Research on the biology is largely TB-4 research; TB-500 is the form usually discussed for administration. Neither is an approved drug, and there's no human head-to-head establishing one as superior.

Why is Thymosin Beta-4 banned in sport?

TB-4 / TB-500 appears on the WADA prohibited list because peptides studied for tissue repair and angiogenesis fall under classes WADA restricts. Being on the list is a regulatory classification for competition — not a verdict on whether it works. Anyone subject to testing should review the current WADA list first.

What has human research found?

Limited. TB-4 has a substantial preclinical literature across wound, cardiac and neural repair models, but human clinical evidence for the recovery uses it's marketed for is thin. Mechanism is not outcome.

What is TB peptide good for?

In research terms, TB-4 is studied as a repair and cell-migration signal — most consistently in wound-healing and cardiovascular models. What it's good for in a person is exactly what human research hasn't settled. It's studied, not proven.

Making sense of before-and-after stories

Personal accounts exist, and some are from real people. Read them as experience, not evidence — a single story can't tell you how often something happens or what else was going on. It's a reason for an informed conversation, not a substitute for one.

TB-500 and BPC-157

These two are discussed together because they're studied in complementary processes — TB-4 in cell migration, BPC-157 in blood-vessel growth. Repair isn't one process; it's several at once. More on BPC-157 →